Guduchi effect on sleep quality in women during the transition to menopause

Effect of Guduchi Churna on Quality of Sleep in Peri-menopausal women: AN open-label Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106785

Enrollment

Registered

2026-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N951- Menopausal and female climactericstates

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Menopausal Rating Scale (MRS) score 12-35 2. Female patients of age 35 55 years. 3. Having different type of disturbed sleep patterns e.g. sleep onset insomnia, sleep maintenance insomnia, nocturnal awakenings. 4. Subjective sleep disturbance defined as Pittsburgh Sleep Quality Index (PSQI) greater than 5 at screening. 5. Perimenopausal women having poor quality of sleep for more than 1 month.

Exclusion criteria

Exclusion criteria: 1. Patient with uncontrolled diabetes, hypertension, any thyroid disorder, and severe obesity. 2. Fatal familial insomniacs. 3. Patients with severe mental illnesses. 4. Surgical menopause. 5. Patients having a known history of major cardiac disease or surgery. 6. Use of Hormonal Replacement Therapy (HRT) 7. History of substance abuse.

Design outcomes

Primary

Measure	Time frame
Assessment of sleep quality using the Pittsburgh Sleep Quality Index (PSQI).Timepoint: Day 1, Day 45	—

Secondary

Measure	Time frame
1.Assessment of signs and symptoms Associated with Poor Quality Of Sleep. 2. Assessment of menopause-specific quality of life using the MENQOL questionnaire. 3. Assessment of Menopausal Rating Scale (MRS). 4. Assessment of serum estradiol. Timepoint: 1. Assessment of Menopausal Rating Scale (MRS)-Day 0,Day 45 2. Assessment of signs and symptoms Associated with Poor Quality Of Sleep- Day 1, Day 45 3. Assessment of menopause-specific quality of life using the MENQOL questionnaire- Day 1, Day 45 4. Assessment of serum estradiol-Day 1, Day 45	—

Measure

Time frame

1.Assessment of signs and symptoms Associated with Poor Quality Of Sleep. 2. Assessment of menopause-specific quality of life using the MENQOL questionnaire. 3. Assessment of Menopausal Rating Scale (MRS). 4. Assessment of serum estradiol. Timepoint: 1. Assessment of Menopausal Rating Scale (MRS)-Day 0,Day 45 2. Assessment of signs and symptoms Associated with Poor Quality Of Sleep- Day 1, Day 45 3. Assessment of menopause-specific quality of life using the MENQOL questionnaire- Day 1, Day 45 4. Assessment of serum estradiol-Day 1, Day 45

—

Countries

India

Contacts

Public ContactProf Dr Sujata Rajan

Ayurvedic and Unani Tibbia College and Hospital karol bagh, New Delhi-110005

Sujataa.rajan@gmail.com9818473595

Outcome results